Loriane advises startups and multinational companies on issues relating to the protection of personal data, privacy and cybersecurity. She focuses her practice on compliance and risk management regarding all aspects of European Union privacy and data protection law. Her clients include startups and large multinational companies operating in sectors such as health, ecommerce and advertising. Loriane has experience in counseling clients on pre-contentious or contentious matters, and on long-term innovative projects involving large-scale data processing activities.
Travere Sells Bile Acid Product Portfolio to Mirum
July 18, 2023
Cooley advised Travere Therapeutics, a biopharmaceutical company, on its definitive agreement to sell its bile acid product portfolio to Mirum Pharmaceuticals.
ACELYRIN Announces Pricing of Upsized Initial Public Offering
May 15, 2023
Cooley advised Acelyrin, INC., a late-stage biopharmaceutical company, in its $621 million initial public offering, the second-largest biotechnology IPO and largest clinical-stage biotechnology IPO ever.
IAA’s Acquisition by Ritchie Bros. Closes Following Shareholder Approval
March 23, 2023
Cooley advised IAA, Inc. (IAA), a global digital marketplace connecting vehicle buyers and sellers, on its cross-border stock and cash acquisition by Ritchie Bros., which closed on Monday, March 20.
Cooley advised Digital Shadows, a company that delivers threat intelligence for security teams, on its agreement to sell to ReliaQuest, a force multiplier of security operations, for $160 million. Partners Rowook Park and Erik Edwards, along with associates Bram Couvreur, Rajdeep Bains, Mary Wilbourn and Omed Sharifi, led the Cooley team advising Digital Shadows.
